SHEENA HAYS: Open Payments
NPI 1598391740 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 21 payments from 10 companies in 2025. Trend: 2023 $63 · 2024 $719 · 2025 $686
Food & beverage: $587Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $153 |
| Janssen Biotech, Inc. | 3 | $142 |
| Teleflex LLC | 4 | $84 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| Alnylam Pharmaceuticals Inc. | 2 | $53 |
| Cycle Pharmaceuticals Inc | 2 | $49 |
| IMMUNITYBIO, INC. | 2 | $48 |
| Laborie Medical Technologies Corp. | 1 | $40 |
| UROGEN PHARMA, INC. | 1 | $24 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $20 |
Products named: ERLEADA, GEMTESA, BARRIGEL, OXLUMO, Venxxiva, ANKTIVA, UROLIFT, PYLARIFY.
Industry payments across CA — which companies pay providers there.
